News Releases – News & Events | Oncolytics Biotech Inc.

News Releases

Latest News Release

Mar 25, 2015

Oncolytics Biotech^® Inc. Announces Receipt of Orphan Drug Status from the EMA for Ovarian Cancer

Mar 16, 2015

Oncolytics Biotech^® Inc. Announces 2014 Year End Results

Mar 5, 2015

Oncolytics Biotech^® Inc. Collaborators Present Preclinical Data on the Combination of REOLYSIN^® and Radiotherapy in Melanoma at the Irish Association for Cancer Research Conference

Mar 3, 2015

Oncolytics Biotech^® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Primary Peritoneal Cancer

Mar 2, 2015

Oncolytics Biotech^® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Cancer of the Fallopian Tube

Feb 18, 2015

Oncolytics Biotech^® Inc. Announces Completion of Enrollment in Randomized Phase II Colorectal Cancer Study

Feb 17, 2015

Oncolytics Biotech^® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Pancreatic Cancer

Feb 11, 2015

Oncolytics Biotech^® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Ovarian Cancer

1
2
3
4
5
6